Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.
from Reuters: Health News https://ift.tt/2TvWm0J
Copyright (c) 2019 todaystimeline.blogspot.com All Right Reseved
0 Comments